Fourpath Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $243K | Sell |
|
|||||
|
2025
Q2 | $276K | Sell |
|
|||||
|
2025
Q1 | $1.36M | Sell |
|
|||||
|
2024
Q4 | $1.39M | Buy |
|
|||||
|
2024
Q3 | $1.25M | Buy |
|
|||||
|
2024
Q2 | $649K | Buy |
|
|||||
|
2024
Q1 | $564K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $336K | Sell |
|
|||||
|
2022
Q2 | $721K | Sell |
|
|||||
|
2022
Q1 | $956K | Buy |
|
|||||
|
2021
Q4 | $470K | Buy |
|